Targeting C-fibers for peripheral acting anti-tussive drugs

Pulm Pharmacol Ther. 2019 Jun:56:15-19. doi: 10.1016/j.pupt.2019.03.002. Epub 2019 Mar 11.

Abstract

Activation of vagal C-fibers is likely involved in some types of pathological coughing, especially coughing that is associated with airway inflammation. This is because stimulation of vagal C-fibers leads to strong urge to cough sensations, and because C-fiber terminals can be strongly activated by mediators associated with airway inflammation. The most direct manner in which a given mediator can activate a C-fiber terminal is through interacting with its receptor expressed in the terminal membrane. The agonist-receptor interaction then must lead to the opening (or potentially closing) of ion channels that lead to a membrane depolarization. This depolarization is referred to as a generator potential. If, and only if, the generator potential reaches the voltage necessary to activate voltage-gated sodium channels, action potentials are initiated and conducted to the central terminals within the CNS. Therefore, there are three target areas to block the inflammatory mediator induced activation of C-fiber terminals. First, at the level of the mediator-receptor interaction, secondly at the level of the generator potential, and third at the level of the voltage-gated sodium channels. Here we provide a brief overview of each of these therapeutic strategies.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Action Potentials / drug effects
  • Animals
  • Antitussive Agents / pharmacology*
  • Cough / drug therapy*
  • Cough / physiopathology
  • Humans
  • Nerve Fibers, Unmyelinated / drug effects*
  • Nerve Fibers, Unmyelinated / metabolism
  • Vagus Nerve / metabolism
  • Voltage-Gated Sodium Channels / drug effects
  • Voltage-Gated Sodium Channels / metabolism

Substances

  • Antitussive Agents
  • Voltage-Gated Sodium Channels